Follow the entities shaping the evidence.

…dications, such as sodium–glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists, which have been shown to reduce cardiovascular and renal outco…

…Introduction While globally cervical cancer is the fourth most common cancer among women, an estimated 90% …

…rther enhanced by increasing the intensity of the interventions.Provider education, including seminars, meetings, and educational materials, is th…

…rgery in well-selected patients. In patients with node-positive PeCa with adverse risk features, treatment intensification with mult…

…ising adjuncts to peripheral nerve blocks are dexamethasone and dexmedetomidine.Dexamethasone Dexamethasone is a glucocorticoid with potent ant…

…n T1D pathogenesis, including therapeutic B cell depletion with rituximab, which preserved beta-cell function for 1 year,38 and variation…

…vascular outcome or the most similar alternative. The composite chronic kidney disease outcome comprised end stage kidney disease, estimated glomerula…

… outcomes between pre-ZDC users and complex users, the baseline Diabetes Complication Severity Index (DCSI) scores in the two groups may…

… and cobalt—has long been recognized as a biochemical action of metformin.1 The chemical properties of complexes formed between metformin…

…suggest that they may have different functions. For example, in colon cancer, ERα upregulation is a risk factor, whereas ERβ upregulation pr…

…nd more women in the frequent user group (63.8%). Patients with covid-19 were on average slightly older than those with acute respirator…

…H, Houssiau F, et al. Two-year, randomized, controlled trial of belimumab in lupus nephritis. N Engl J Med. 2020;383(12):1117–28. doi: 10…